Amolyt Pharma to Present New Phase 1 Data on AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, and Preclinical Data on AZP-3404 at Upcoming Scientific Conferences

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing